key: cord-0892490-iu0chom9 authors: Gholivand, Khodayar; Mohammadpanah, Fahimeh; Pooyan, Mahsa; Roohollah Roohzadeh title: Evaluating anti-coronavirus activity of some phosphoramides and their influencing inhibitory factors using molecular docking, DFT, QSAR, and NCI-RDG studies date: 2021-09-12 journal: J Mol Struct DOI: 10.1016/j.molstruc.2021.131481 sha: edf21e64bed25cfc17d196d92ab2ec7d7a9717dd doc_id: 892490 cord_uid: iu0chom9 The recent prevalence of coronavirus disease in 2019 (COVID-19) has triggered widespread global health concerns.Antiviral drugs based on phosphoramides have significant inhibitory activity against the main protease (M(pro)) of the virus and prevent transcription and viral replication. Hence, in order to design and introduce a group of inhibitors affecting the coronavirus, 35 phosphoramide compounds based on phospho-guanine and phospho-pyrazine derivatives were selected for molecular docking study. The results showed that most phosphoguanides containing the amino benzimidazole have a high interaction tendency with COVID-19. Among them, compound 19 was identified as the strongest inhibitor with the -9.570 kcal/mol binding energy whereas, the binding energy of Remdesivir is -6.75 kcal/mol. The quantitative structure-activity relationship (QSAR) results demonstrated that the number of aromatic rings, amide's nitrogens and their ability in π-staking, and hydrogen interactions with M(pro) active sites are major factors contributing to the inhibitory activity of these compounds.Also, the NCI-RDG and DFT results were in good accordance with those of QSAR and molecular docking. The findings of this investigation can be underlying the synthesis of effective and efficient drugs against COVID-19. significant inhibitory activity against the main protease (M pro ) of the virus and prevent transcription and viral replication. Hence, in order to design and introduce a group of inhibitors affecting the coronavirus, 35 phosphoramide compounds based on phosphoguanine and phospho-pyrazine derivatives were selected for molecular docking study. The results showed that most phosphoguanides containing the amino benzimidazole have a high interaction tendency with COVID-19. Among them, compound 19 was identified as the strongest inhibitor with the -9.570 kcal/mol binding energy whereas, the binding energy of Remdesivir is -6.75 kcal/mol. The quantitative structure-activity relationship (QSAR) results demonstrated that the number of aromatic rings, amide's nitrogens and their ability in π-staking, and hydrogen interactions with M pro active sites are major factors contributing to the inhibitory activity of these compounds.Also, the NCI-RDG and DFT results were in good accordance with those of QSAR and molecular docking. In recent months, the world has been facing a widespread illness known as "Coronavirus disease-2019 (COVID-19)" which has affected the global health and economy [1] . COVID-19 is a respiratory disease that might be causing fever, malaise, dry cough, pneumonia, and even to death [2, 3] . There hasn't produced any safe and accepted medications to treat or prevent this infection yet [4] . Scientists around the world are attempting to achieve an effective drug for this global pressing problem [5, 6] . Effective antiviral drugs based on phosphorus amide and phosphate with pyrazin and imidazole rings in their structure such as Adefovir, Foscarnet, Tenofovir, Sofosbuvir, Uprifosbuvir, and Remdesivir have been examined for the treatment of COVID-19 [7] . These drugs are efficient against Hepatitis, HIV, Influenza, and Ebola viral diseases [7] . Among these compounds, Remdesivir (GS-5734) was believed to be the most promising drug which can be used for treatment against COVID-19 [8] . This compound is a mono phosphoramidate prodrug with a broad-spectrum antiviral activity against pneumoviruses, paramyxoviruses, filoviruses, and coronaviruses [8, 9] , clinical tests are presently conducting to specify the complete efficacy of this prodrug in patients [10, 11] . Recent studies reveal that the acting mechanism of the abovementioned drugs is through inhibiting the main protease of the virus. Indeed, the inhibition potential of the main protease (M pro ) is the most hopeful drug target against coronaviruses [12] [13] [14] [15] [16] . The broadly used in modern drug design, molecular docking methods explore the ligand conformations adopted within the binding sites of macromolecular targets [17, 18] . These procedures are logically successful for the prediction of binding affinity and have shown promising potential in facilitating drug design [19] . Hence, in this work, due to the need to discover new inhibitors and factors affecting M pro inhibition, an attempt will be made to introduce new inhibitors based on phosphoramides with the higher COVID-19 M pro inhibition potential than current acceptable drugs by molecular docking method. Many of synthetic and natural physiologically active compounds are of the guanidine and pyrazine motifs in their structures [20, 21] . These bioactive compounds exhibit a variety of pharmaceutical properties such as anticancer agent [22] , HIV protease inhibitor [23, 24] , anti-malarial [25] , histamine H2 receptor antagonist [26] , anti-hepatitis [27] , antimicrobial [28] , fungicidal [29] , antimalarial [25] , and anti-inflammatory [28] . Some research proves that phosphorylation of various drugs may be able to increase their biological activity [30] . There are compounds containing phospho guanidine and phospho pyrazine which represent agricultural and medicinal applications. Additionally, we have recently reporteed some of these compounds with both abilities to inhibits the acetylcholinesterase enzyme and low human toxicity. [31] [32] [33] Among the various phosphoramide derivatives [31, [33] [34] [35] , we have studied phosphoguanidines and phosphopyrazines as effective compounds in drug design because of their extensive biological properties [31, 33] . Due to the fact that Phosphoramides are able to inhibit the main protease [36] , In this work we selected 35 phosphoramide compounds including the guanidine and pyrazine with the general formula (R1)(R2)P(X)-Y, that X=O or S, Y= creatine, amino pyrazine, amino benzimidazole, or amino pyrimidines, R1=(C6H5, OC6H5, OCH3, or OCH2CH3), and R2=(R, Y) ( Figure 1 , Table 1 The results of docking analysis indicated that compounds containing amino pyrimidine and amino benzimidazole substitutions have a higher inhibitory effect and lower binding energy than those containing creatine substitutions. Additionally, this class of compounds displays different trends to interact with protease, depending on the different attached substitutions to the phosphorus atom and pyrimidine rings ( Figure. 2). The extracted data from the docking simulation such as free binding energy and inhibition constants (Ki) are presented in Table 2 . Accordingly, the lowest and highest free binding energy belong to compounds 19 respectively. Furthermore, aromatic rings were connected to Glu143, Cys145, and Met165 via π-Alkyl bonds and also to His163 and Cys145 residues through the π-π and π-sulfur interactions. These interactions have led to more stability of the target complex. In general, the connection desire of the inhibitors to COVID-19 protease depends on the position, size, volume, type of inhibitors' substituents, and their ability to form hydrogen interactions and π-stacking with active sites of the protease. In accordance with these studies and to obtain a rational relationship between the structure and activity of compounds, the QSAR study was conducted. The dotted lines illustrate various interactions between 19 and the active site residues, which including hydrogen bond (green), π-anion (Orange), π-π (Purple) and π-alkyl (pink) interactions Table 3 . The predicted binding energies are listed in Table 1 , and the relationship between the predicted and the calculated values of the biological activity (binding energy) are shown in Figure 4 . Cross-validation methods such as Leave-One-Out (LOO) and Leave-Multiple-Out (LMO) were also utilized to further validation of the performed model. In the former, one molecule acts as a prediction set and the other molecules develop the model, whereas, in the latter, some of the molecules (M) are considered as a prediction set. In LMO, it is supposed M=6, and the L6O model is repeated 200 times. The LOO and L6O data have been shown in Table 3 . Descriptors nitrogens) have a greater and better effect on the virus than intra-ring nitrogen, due to their ability to form hydrogen bonds with the active sites of the COVID-19. The HOMO orbitals of a chemical species are very important to define its reactivity [31] . And the greater its amount, the more reactive is the compound or the better interaction with the active site of the COVID-19 M pro . Mv is one of the descriptors of this model, which displays the importance of In order to better understand the results of docking and QSAR studies on the more inhibition activity of derivatives containing both phosphoryl groups and aromatic systems in comparison to the compounds containing the thiophosphoryl and aliphatic group also determining the active sites in the structure of the molecules, their density functional theory (DFT) calculations including molecule electrostatic surface potential (MEP), frontier molecular orbitals (HOMO, LUMO),and reduced density gradient (RDG) were calculated. The molecular electrostatic potential surfaces are extensively used in the analysis of the molecular stability, dipole moment, finding of the molecular active areas in electrophilic or nucleophilic reactions, hydrogen bonds, identifying the bioactive molecules, and predicting applied sites [39] . Regarding the molecular overall charge distribution, each area on the surface has been recognized in different colors. In the following MEP maps, the red color represents the electron-rich zone and known as a nucleophilic center. The blue color is also attributed to electron- The analysis of Frontier molecular orbitals of compounds is one of the methods used to predict reactive electrophilic or nucleophilic sites. The highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO) are called frontier molecular orbitals. The energy values of HOMO and LUMO orbitals and their energy gap provide information about the biological activity of the compounds [40] . Compounds that have a small energy gap are more polarizable and generally more chemical reactivity [41] . HOMO-LUMO energies of compounds were calculated using DFT at B3LYP Reactivity descriptors such as Ionization potential (IP), Electron affinity (EA), Chemical hardness ( ) and Softness (S), chemical potential ( ), and Electrophilicity index ( ) are descriptors used to predict a drug's tendency to engage in Drug-acceptor interactions and also, to explain their properties and chemical activities [45] . The values of Global molecular reactivity descriptors of compound 19 were calculated using HOMO and LUMO energies from the following relationships, Table 4 : have been calculated 1.485 eV and -17.728 eV, respectively. With respect to the fact that whenever > 0 and ∆ < 0, the charge transition process is desirable in terms of energy [46] , the desirability of these values for compound 19 indicates its tendency to interact with the COVID-19 acceptor as a bioactive molecule. If the ratio between the energy changes and the maximum charge acceptance is zero ∆ (E / ∆Nmax = 0), it will indicate that the compound is electron saturated and has no tendency to participate in the charge transfer process [47] . This value for compound 19 is calculated -3.629 which indicated its ability to charge transfer and interact with the acceptor. Reduced density gradient (RDG) is a non-dimensional principal quantity based on electron density ( ) and its first derivation. This highly efficient method to analyze weak interactions has been developed by Johnson et al [48] . In order to better imagination of interactions, RDG plots related to compounds 5, 16, and 19 were plotted using Multiwfn 3.7 [42] and VMD 1.9.3 [49] softwares in Figure 9 . In In this study, the aim was to find compounds with a higher potential of inhibiting COVID-19 M pro than the current acceptable drugs. For this reason, we have undertaken docking, QSAR, and other computational investigations on 35 phosphoramide compounds based on the guanidine and pyrazines against COVID-19 M pro .One of which (19) showed remarkable binding interactions with the target better than the Remdesivir. Taken together, this study help to gain a better understanding of the interactions between the COVID-19 main protease and its inhibitors, which in turn assist in the exploration, develop and design of the anti-coronavirus drugs. In sum, 35 phosphoramides containing guanidine substitutions (including creatine and pyrimidine and the amino benzimidazole) and pyrazine substitution were selected among our previously reported data (Table 1 ) [31] . The toxicity of these compounds to humans has been investigated by measuring the anti-acetylcholinesterase activity. The mentioned compounds have been studied as antiviral agents for COVID-19 via docking, QSAR, and MEP. In order to investigate the conformation and determine the orientation of the compounds within the active site of the enzyme, molecular docking was performed using Auto Dock 4.2 software. The crystal structure of the COVID-19 (PDB ID: 6LU7) was used in this study [6] . To prepare proteins and ligands, firstly, the structures of all inhibitors were fully optimized at the B3LYP / 6-311G ** level of DFT theory [51] . All the water molecules were removed from the protein structure and hydrogens were added to the structure. One hundred docking runs through Lamarckian genetic algorithm were performed and According to the default settings, the docking parameters were set. Results that less differ than 0.5 Å in Root Mean Square Deviation (RMSD) to each other were clustered together then, these optimized clusters based on the lowest binding energy were ranked. Finally, the cluster which has the lowest binding energy and the highest number of conformations was selected as the bestdocked conformation. Since nonlinear methods consider both linear and nonlinear properties between dependent and independent variables, nonlinear ones are more suitable for selecting descriptors [55] . In this work, the correlation between binding energy and structural properties was achieved using a genetic algorithm-artificial neural network (GA-ANN) in MATLAB software (version 8.5.0 (R2015a)). The best selected-descriptors utilizing a genetic algorithm (GA) have been used as input variables for the development of an artificial neural network (ANN) model. In the GA-ANN method, ANN is used as a fitness approximation and GA to perform robust and effective evolutionary optimization. The theory of this method has been adequately described elsewhere [57] . In order to evaluate the generated models, the parameters of the correlation coefficient (R), root mean square error (RMSE), leave-one-out cross-validation (LOO-CV), and Leave-multiple-out cross-validation (LMO-CV) approaches were used. In LOO-CV, one compound is removed at each step as a prediction set and the model is developed using the remaining molecules as the training set. Also, a group of six compounds randomly selected to perform the authentication method of leave-6-out (L6O) cross-validation. Organization, W.h. organization, Coronavirus disease (COVID-2019) situation reports Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, The lancet A novel coronavirus from patients with pneumonia in China Dataset on the COVID-19 Pandemic Situation in Tunisia with application to SIR Model, medRxiv Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro Structure of M pro from SARS-CoV-2 and discovery of its inhibitors silico studies on therapeutic agents for COVID-19: Drug repurposing approach Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase Feng, I. Trantcheva, Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses Treatment Trial. ClinicalTrials. gov identifier: NCT04280705. Posted Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease Rapid identification of potential inhibitors of SARS-CoV-2 main protease by deep docking of 1.3 billion compounds Coronaviruses-drug discovery and therapeutic options The process of structure-based drug design Molecular docking and structure-based drug design strategies Computer aided drug design for multitarget drug design: SAR/QSAR, molecular docking and pharmacophore methods Natural guanidine derivatives Imidazole and its biological activities: A review Amine− guanidine switch: A promising approach to improve DNA binding and antiproliferative activities Recent Advances in Antiviral Benzimidazole Derivatives: A Mini Review Preliminary SAR and biological evaluation of potent HIV-1 protease inhibitors with pyrimidine bases as novel P2 ligands to enhance activity against DRV-resistant HIV-1 variants Structure-activityrelationship studies around the 2-amino group and pyridine core of antimalarial 3, 5-diarylaminopyridines lead to a novel series of pyrazine analogues with oral in vivo activity Highly potent, stable, and selective dimeric hetarylpropylguanidine-type histamine H2 receptor agonists Design, synthesis, and biological evaluation of triazolopyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion El-Emam, Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1, 3, 4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1, 3, 4-thiadiazoles Synthesis, fungicidal activity, and 3D-QSAR of pyridazinone-substituted 1, 3, 4-oxadiazoles and 1, 3, 4-thiadiazoles Synthesis of novel phosphorylated guanidine derivatives from cyanamide and their anti-inflammatory activity Synthesis, crystal structure, insecticidal activities, molecular docking and QSAR studies of some new phospho guanidines and phospho pyrazines as cholinesterase inhibitors, Pesticide biochemistry and physiology Synthesis of phosphinyl, thiophosphinyl and phosphonio guanidines Diphenyl phosphate creatine immobilized on magnetite nanoparticles: an efficient and recyclable catalyst for Aza-Michael reaction Synthesis, crystal structure, fluorescence assay, molecular docking and QSAR/QSPR studies of Temephos derivatives as human and insect cholinesterase inhibitors Synthesis, crystal structure and biological evaluation of new phosphoramide derivatives as urease inhibitors using docking, QSAR and kinetic studies In silico study of various antiviral drugs, vitamins, and natural substances as potential binding compounds with SARS-CoV-2 main protease Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: An in silico strategy unveils a hope against CORONA Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease Hydrogen bonding, electrostatic potential, and molecular design Spectroscopic investigations and quantum chemical computational study of (E)-4-methoxy-2-[(p-tolylimino) methyl] phenol Interaction of a series of nitriles with the alcoholinducible isoform of P450: Computer analysis of structure-activity relationships Multiwfn: a multifunctional wavefunction analyzer Frontier orbitals and organic chemical reactions Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and spike (S) glycoprotein inhibitors: a molecular docking study Electrophilicity index as a possible descriptor of biological activity Electrophilicity index Absolute hardness: companion parameter to absolute electronegativity Revealing noncovalent interactions VMD: visual molecular dynamics Non-covalent interaction via the reduced density gradient: Independent atom model vs experimental multipolar electron densities Intermolecular interactions from a natural bond orbital, donor-acceptor viewpoint LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions, Protein engineering, design and selection BIOVIA, discovery studio modeling environment DRAGON-Software for the calculation of molecular descriptors, Web version GAUSSIAN 03 Quantitative structure-activity/ecotoxicity relationships (QSAR/QEcoSAR) of a series of phosphonates A hybrid genetic algorithm-neural network strategy for simulation optimization We would like to thank our colleagues from the University of Tarbiat Modares who provided valuable insights.